|
1
|
Effects of torcetrapib in patients at high risk for coronary events.
|
N Engl J Med
|
2007
|
18.78
|
|
2
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
|
Circulation
|
2006
|
8.01
|
|
3
|
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
|
N Engl J Med
|
2006
|
6.14
|
|
4
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
|
Circulation
|
2011
|
5.26
|
|
5
|
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
|
Circulation
|
2011
|
4.65
|
|
6
|
The effects of tibolone in older postmenopausal women.
|
N Engl J Med
|
2008
|
3.96
|
|
7
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
Circulation
|
2004
|
3.39
|
|
8
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2006
|
2.57
|
|
9
|
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.
|
J Am Coll Cardiol
|
2011
|
2.45
|
|
10
|
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
|
Circulation
|
2009
|
2.41
|
|
11
|
Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study.
|
J Womens Health (Larchmt)
|
2007
|
2.08
|
|
12
|
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.
|
Circulation
|
2005
|
1.97
|
|
13
|
American Heart Association and American Stroke Association national survey of stroke risk awareness among women.
|
Circulation
|
2005
|
1.95
|
|
14
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
|
J Am Coll Cardiol
|
2007
|
1.69
|
|
15
|
Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project.
|
Stroke
|
2003
|
1.61
|
|
16
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
J Am Coll Cardiol
|
2004
|
1.59
|
|
17
|
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.
|
J Natl Cancer Inst
|
2008
|
1.56
|
|
18
|
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.55
|
|
19
|
Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey.
|
Circulation
|
2013
|
1.52
|
|
20
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.49
|
|
21
|
Controversy and consensus about statin use: it is not about the sex.
|
J Am Coll Cardiol
|
2012
|
1.45
|
|
22
|
Epidemiology of coronary heart disease in women.
|
Prog Cardiovasc Dis
|
2004
|
1.27
|
|
23
|
Quality of cardiovascular disease preventive care and physician/practice characteristics.
|
J Gen Intern Med
|
2006
|
1.19
|
|
24
|
Influence of caregiving on lifestyle and psychosocial risk factors among family members of patients hospitalized with cardiovascular disease.
|
J Gen Intern Med
|
2008
|
1.18
|
|
25
|
Clinical utility of a fingerstick technology to identify individuals with abnormal blood lipids and high-sensitivity C-reactive protein levels.
|
Am J Health Promot
|
2009
|
1.07
|
|
26
|
Cholesterol predicts stroke mortality in the Women's Pooling Project.
|
Stroke
|
2002
|
1.04
|
|
27
|
Association of acculturation status with beliefs, barriers, and perceptions related to cardiovascular disease prevention among racial and ethnic minorities.
|
J Transcult Nurs
|
2009
|
1.03
|
|
28
|
Gender disparities in the quality of cardiovascular disease care in private managed care plans.
|
Womens Health Issues
|
2007
|
1.02
|
|
29
|
Prevalence of breast arterial calcifications in an ethnically diverse population of women.
|
Ann Epidemiol
|
2005
|
1.01
|
|
30
|
The gender gap in coronary heart disease mortality: is there a difference between blacks and whites?
|
J Womens Health (Larchmt)
|
2005
|
1.01
|
|
31
|
Limitations of current cardiovascular disease risk assessment strategies in women.
|
J Womens Health (Larchmt)
|
2006
|
1.00
|
|
32
|
Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey.
|
Arch Intern Med
|
2003
|
1.00
|
|
33
|
C-reactive protein--to screen or not to screen?
|
N Engl J Med
|
2002
|
1.00
|
|
34
|
Knowledge, preventive action, and barriers to cardiovascular disease prevention by race and ethnicity in women: an American Heart Association national survey.
|
J Womens Health (Larchmt)
|
2010
|
0.99
|
|
35
|
Lifestyle and psychosocial risk factors predict non-adherence to medication.
|
Ann Behav Med
|
2010
|
0.98
|
|
36
|
Relationship between arterial stiffness and subclinical aortic atherosclerosis.
|
Circulation
|
2004
|
0.98
|
|
37
|
The association between educational level and risk of cardiovascular disease fatality among women with cardiovascular disease.
|
Womens Health Issues
|
2005
|
0.97
|
|
38
|
Reduced bone mineral density is associated with breast arterial calcification.
|
J Clin Endocrinol Metab
|
2007
|
0.97
|
|
39
|
Validation of the MEDFICTS dietary assessment questionnaire in a diverse population.
|
J Am Diet Assoc
|
2008
|
0.97
|
|
40
|
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial.
|
Am J Cardiol
|
2002
|
0.96
|
|
41
|
Physical activity as a potential mechanism through which social support may reduce cardiovascular disease risk.
|
J Cardiovasc Nurs
|
2008
|
0.95
|
|
42
|
Ethnic differences in barriers and referral to cardiac rehabilitation among women hospitalized with coronary heart disease.
|
Prev Cardiol
|
2006
|
0.94
|
|
43
|
Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.
|
J Bone Miner Res
|
2008
|
0.93
|
|
44
|
The effect of patient choice of intervention on health outcomes.
|
Contemp Clin Trials
|
2008
|
0.93
|
|
45
|
Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population.
|
Prev Cardiol
|
2007
|
0.93
|
|
46
|
Spotlight on gender.
|
Cardiovasc Res
|
2002
|
0.91
|
|
47
|
Low social support level is associated with non-adherence to diet at 1 year in the Family Intervention Trial for Heart Health (FIT Heart).
|
J Nutr Educ Behav
|
2010
|
0.91
|
|
48
|
Racial/ethnic and age differences in women's awareness of heart disease.
|
J Womens Health (Larchmt)
|
2012
|
0.88
|
|
49
|
The relation of blood pressure to coronary heart mortality in different age groups varies by ethnicity.
|
Am J Hypertens
|
2006
|
0.88
|
|
50
|
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease.
|
Circulation
|
2004
|
0.88
|
|
51
|
National women's knowledge of stroke warning signs, overall and by race/ethnic group.
|
Stroke
|
2014
|
0.87
|
|
52
|
Aspirin chemoprevention: one size does not fit all.
|
Circulation
|
2008
|
0.87
|
|
53
|
Raloxifene and risk for stroke based on the framingham stroke risk score.
|
Am J Med
|
2009
|
0.87
|
|
54
|
Caregiver status: a simple marker to identify cardiac surgery patients at risk for longer postoperative length of stay, rehospitalization, or death.
|
J Cardiovasc Nurs
|
2013
|
0.86
|
|
55
|
Predictors of quality of life among women with coronary heart disease.
|
Qual Life Res
|
2006
|
0.85
|
|
56
|
Medication adherence is associated with having a caregiver among cardiac patients.
|
Ann Behav Med
|
2013
|
0.84
|
|
57
|
Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.
|
CMAJ
|
2013
|
0.84
|
|
58
|
Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men.
|
Am J Cardiol
|
2005
|
0.84
|
|
59
|
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report.
|
Circulation
|
2002
|
0.82
|
|
60
|
Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women.
|
Clin Cardiol
|
2005
|
0.82
|
|
61
|
Does stage of change modify the effectiveness of an educational intervention to improve diet among family members of hospitalized cardiovascular disease patients?
|
J Am Diet Assoc
|
2010
|
0.81
|
|
62
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.81
|
|
63
|
Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.
|
Am J Cardiol
|
2003
|
0.81
|
|
64
|
Predictors and barriers to timely medical follow-up after cardiovascular disease risk factor screening according to race/ethnicity.
|
J Natl Med Assoc
|
2008
|
0.81
|
|
65
|
Lifestyle changes in New Yorkers after September 11, 2001 (data from the Post-Disaster Heart Attack Prevention Program).
|
Am J Cardiol
|
2002
|
0.80
|
|
66
|
Self-reported physical activity and myocardial flow reserve in postmenopausal women at risk for cardiovascular disease.
|
J Womens Health (Larchmt)
|
2006
|
0.79
|
|
67
|
Usefulness of self-reported periodontal disease to identify individuals with elevated inflammatory markers at risk of cardiovascular disease.
|
Am J Cardiol
|
2008
|
0.79
|
|
68
|
Predictors of physical activity at 1 year in a randomized controlled trial of family members of patients with cardiovascular disease.
|
J Cardiovasc Nurs
|
2010
|
0.79
|
|
69
|
Effect of gender, caregiver, on cholesterol control and statin use for secondary prevention among hospitalized patients with coronary heart disease.
|
Am J Cardiol
|
2012
|
0.79
|
|
70
|
Heart disease management by women: does intervention format matter?
|
Health Educ Behav
|
2007
|
0.78
|
|
71
|
Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease.
|
Am Heart J
|
2013
|
0.78
|
|
72
|
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials.
|
Circulation
|
2004
|
0.78
|
|
73
|
Psychosocial factors predict coronary heart disease, but what predicts psychosocial risk in women.
|
J Am Med Womens Assoc
|
2003
|
0.77
|
|
74
|
Postmenopausal hormone replacement therapy and atherosclerosis.
|
Curr Atheroscler Rep
|
2002
|
0.77
|
|
75
|
Association of blood pressure indices and stroke mortality in isolated systolic hypertension.
|
Stroke
|
2005
|
0.76
|
|
76
|
Usefulness of arterial compliance in the thigh in predicting exercise capacity in individuals without coronary heart disease.
|
Am J Cardiol
|
2005
|
0.76
|
|
77
|
Hormone replacement therapy trials: an update.
|
Curr Atheroscler Rep
|
2002
|
0.76
|
|
78
|
Caregiver burden and nonachievement of healthy lifestyle behaviors among family caregivers of cardiovascular disease patients.
|
Am J Health Promot
|
2012
|
0.75
|
|
79
|
Exercise self-regulation among older women participating in a heart disease-management intervention.
|
J Women Aging
|
2010
|
0.75
|
|
80
|
Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease.
|
J Lab Clin Med
|
2002
|
0.75
|
|
81
|
Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence.
|
Am J Cardiol
|
2010
|
0.75
|
|
82
|
Sex, age, and race/ethnicity do not modify the effectiveness of a diet intervention among family members of hospitalized cardiovascular disease patients.
|
J Nutr Educ Behav
|
2011
|
0.75
|
|
83
|
The role of worksite health screening: a policy statement from the American Heart Association.
|
Circulation
|
2014
|
0.75
|
|
84
|
Physical activity goals for sedentary patients.
|
Am Fam Physician
|
2004
|
0.75
|
|
85
|
Carotid artery reactivity to isometric hand grip exercise identifies persons at risk and with coronary disease.
|
Atherosclerosis
|
2002
|
0.75
|
|
86
|
Lori Mosca, MD, PhD: raising awareness of heart disease risks in women. Interview by Mike Mitka.
|
JAMA
|
2005
|
0.75
|
|
87
|
Physical activity and coronary heart disease: prevention and effect on risk factors.
|
Cardiol Rev
|
2002
|
0.75
|
|
88
|
Report of the American Heart Association Task Force on Strategic Research Direction: executive summary.
|
Circulation
|
2002
|
0.75
|
|
89
|
Novel cardiovascular risk factors: do they add value to your practice?
|
Am Fam Physician
|
2003
|
0.75
|